HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michio Sawada Selected Research

VAP-cyclo protocol

6/2017CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
10/2013Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
2/2004Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
11/2002[Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michio Sawada Research Topics

Disease

10Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2018 - 06/2006
6Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2013 - 06/2002
3Cardiotoxicity
10/2018 - 02/2004
3Lymphoma (Lymphomas)
02/2012 - 11/2002
2Neutropenia
02/2022 - 12/2005
2Febrile Neutropenia
02/2022 - 06/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2018 - 08/2007
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2017 - 01/2009
2Neoplasms (Cancer)
02/2005 - 11/2002
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2022
1Thrombocytopenia (Thrombopenia)
02/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2022
1Stomatitis
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2012
1Hematologic Neoplasms (Hematological Malignancy)
06/2008
1Fever (Fevers)
12/2005
1Hepatitis B
02/2005
1Virus Diseases (Viral Diseases)
02/2005
1Niemann-Pick Diseases (Niemann Pick Disease)
12/2004
1Inborn Genetic Diseases (Disease, Hereditary)
12/2004
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
12/2004
1Primary Myelofibrosis (Myelosclerosis)
08/2003
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2003
1Tumor Lysis Syndrome
11/2002
1Cytokine Release Syndrome
11/2002
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2002
1Multiple Organ Failure (MODS)
11/2002
1Disease Progression
11/2002
1Necrosis
07/2002

Drug/Important Bio-Agent (IBA)

11Prednisolone (Predate)FDA LinkGeneric
10/2018 - 06/2002
11Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 06/2002
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018 - 06/2002
9Rituximab (Mabthera)FDA Link
02/2022 - 10/2009
9Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 02/2004
6pirarubicinIBA
10/2018 - 02/2004
3Carboplatin (JM8)FDA LinkGeneric
09/2017 - 06/2002
3Etoposide (VP 16)FDA LinkGeneric
09/2017 - 06/2002
3Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2009 - 11/2002
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2022 - 08/2007
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2022 - 12/2005
2Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 06/2002
2MethylprednisoloneFDA LinkGeneric
09/2017 - 08/2003
2IfosfamideFDA LinkGeneric
09/2017 - 06/2002
2Type II Tumor Necrosis Factor ReceptorsIBA
10/2013 - 09/2006
2Interleukin-18 (Interleukin 18)IBA
09/2011 - 11/2002
1Bendamustine HydrochlorideFDA Link
02/2022
1polaprezinc (Z 103)IBA
01/2021
12- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA
06/2017
1AnthracyclinesIBA
06/2017
1biapenem (L 627)IBA
06/2008
1Proteins (Proteins, Gene)FDA Link
06/2006
1DNA (Deoxyribonucleic Acid)IBA
06/2006
1Fas Ligand Protein (Fas Ligand)IBA
06/2006
1CholesterolIBA
12/2004
1Filipin (Filipin III)IBA
12/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2003
1Interferon-gamma (Interferon, gamma)IBA
11/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2002

Therapy/Procedure

8Therapeutics
02/2022 - 06/2002
6Drug Therapy (Chemotherapy)
01/2021 - 06/2002
4VAP-cyclo protocol
06/2017 - 11/2002
1Platelet Transfusion (Blood Platelet Transfusions)
02/2022
1Transplantation
01/2021
1Hematopoietic Stem Cell Transplantation
01/2021
1Aftercare (After-Treatment)
10/2009
1Intravenous Infusions
08/2007